Denmark Publishes Emergency Grid Law That Puts Data Centers Last
(Bloomberg) — Denmark introduced an emergency law to overhaul access to its power grid, including by making most…
Vestas Jumps Most in Four Years on Higher Profit Guidance
(Bloomberg) — Vestas Wind Systems A/S surged as much as 19%, the most since July 2022, after the…
Vestas Jumps Most in Four Years on Higher Profit Guidance
(Bloomberg) — Vestas Wind Systems A/S surged as much as 19%, the most since July 2022, after the…
Novo Nordisk’s Defining Moment: Can a Pill Outweigh a Pipeline Setback?
The arithmetic of Novo Nordisk’s share price has become uncomfortably simple. At Monday’s close of 40.83 euros, the…
Novo Nordisk’s Pipeline and Buyback Offer Twin Props as Wegovy Prescriptions Cool
For Novo Nordisk, the contrast between long-term promise and near-term pressure has rarely been starker. On one side,…
Novo Nordisk’s India Insulin Push and Aggressive Buyback Counterbalance a Pipeline Jolt
Novo Nordisk ended the week at €43.32, a 1.29% gain on Friday that masked a slightly negative weekly…
Denmark commits $660M to Ukraine arms pipeline
The Danish Defense Ministry reported on June 30 that Denmark will supply Ukraine with a new military aid…
Novo Nordisk Finds a Few Bright Spots as Its Pipeline Takes Centre Stage
Novo Nordisk is trying to turn the spotlight away from weaker near-term trading and toward what comes next.…
Novo Nordisk’s Pipeline Paradox: A $55 Billion Bet on Automation and a Quiet Drug Revolution
The market has handed Novo Nordisk a brutal 40% haircut over the past year, and the bears have…
Novo Nordisk’s Bear Case Is Priced In — But the Pipeline Tells a Different Story
The market has spent the past year punishing Novo Nordisk shares, slicing nearly 40% off the stock in…
Novo Nordisk’s Pipeline and China Push Chip Away at a 41% Stock Decline
Two narratives are competing for Novo Nordisk’s share price. One points to a stock that is trading at…
Novo Nordisk Scores UK First for Oral Wegovy, but Pipeline and Price Pressures Cap the Rally
Novo Nordisk has secured a landmark regulatory nod for its oral version of Wegovy in Britain, yet the…